🔎 Trials Near Me

Utama › Dermatitis Atopik (Eksim) › Maryland

Kajian klinikal Dermatitis Atopik (Eksim) di Maryland

16 kajian untuk Dermatitis Atopik (Eksim) sedang mencari peserta di lokasi di Maryland.

Bandar di Maryland

Teks kajian rasmi (Bahasa Inggeris)

Natural History and Genetics of Food Allergy and Related Conditions

  • National Institutes of Health Clinical Center, Bethesda
Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukan
1 Day – 99 Years · Semua jantina · Dikemas kini 2 Okt 2026 · NCT02504853

Evaluating the Safety and Tolerability of Baricitinib in Patients With Job Syndrome With Lupus-Like Disease and/or Atopic Dermatitis

  • National Institutes of Health Clinical Center, Bethesda
Mengambil pesertaFasa 1
Umur 12 hingga 120 · Semua jantina · Dikemas kini 2 Okt 2026 · NCT07262983

Effects of Treatments on Atopic Dermatitis

  • National Institutes of Health Clinical Center, Bethesda
Mengambil pesertaFasa 2Sukarelawan sihat dialu-alukan
Umur 2 hingga 50 · Semua jantina · Dikemas kini 28 Sep 2026 · NCT01631617

A Long-term Safety and Efficacy Study Evaluating APG777 in Atopic Dermatitis

  • Investigational Site, Rockville
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 23 Sep 2026 · NCT07003425

Metabolic Profiling of Immune Responses in Immune-mediated Diseases

  • National Institutes of Health Clinical Center, Bethesda
Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukan
Umur 18 hingga 75 · Semua jantina · Dikemas kini 22 Sep 2026 · NCT04864886

Studies of Skin Microbes in Healthy People and in People With Skin Conditions

  • National Institutes of Health Clinical Center, Bethesda
Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukan
Umur 2 hingga 100 · Semua jantina · Dikemas kini 16 Sep 2026 · NCT00605878

Evaluation of a Non-Invasive Device for Early Detection of Atopic Dermatitis Flares

  • U.S. Dermatology Partners Rockville, Rockville
Mengambil pesertaKajian pemerhatian
Umur 12 hingga 89 · Semua jantina · Dikemas kini 15 Sep 2026 · NCT07645820

A Phase 2b Study of the Effects of Camoteskimab in Adults With Moderate-to-Severe Atopic Dermatitis

  • Chesapeake Clinical Research, Inc, Pasadena
Mengambil pesertaFasa 2
Umur 18 hingga 65 · Semua jantina · Dikemas kini 28 Ogo 2026 · NCT07599813

Food-Specific and Component IgE Threshold Levels That Predict Food Allergy in People With Elevated Total Serum IgE Levels and Atopic Dermatitis

  • National Institutes of Health Clinical Center, Bethesda
Mengambil pesertaFasa 2
Umur 3 hingga 21 · Semua jantina · Dikemas kini 26 Ogo 2026 · NCT03835767

Cardamom and Topical Roseomonas in Atopic Dermatitis

  • National Institutes of Health Clinical Center, Bethesda
Mengambil pesertaFasa 2
Umur 2 hingga 100 · Semua jantina · Dikemas kini 13 Ogo 2026 · NCT06096857

A Study to Assess Adverse Events and Change in Disease Activity Comparing Oral Upadacitinib to Subcutaneous Dupilumab in Children From 2 to Less Than 12 Years of Age With Moderate to Severe Atopic Dermatitis

  • Maryland Allergy & Asthma Center /ID# 268032, Lanham
Mengambil pesertaFasa 3
Umur 2 hingga 11 · Semua jantina · Dikemas kini 6 Ogo 2026 · NCT06461897

A Biorepository of Multiple Allergic Diseases (MADREP) With Longitudinal Follow-Up

  • National Institutes of Health Clinical Center, Bethesda
Mengambil pesertaKajian pemerhatian
Umur 3 hingga 100 · Semua jantina · Dikemas kini 17 Jul 2026 · NCT06732414

A Study To Learn About Two Study Medicines (PF-07275315 And PF-07264660) In People Who Have Moderate To Severe Atopic Dermatitis

  • Maryland Laser Skin and Vein, Hunt Valley
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 4 Mei 2026 · NCT05995964

Dupilumab De-escalation in Pediatric Atopic Dermatitis

  • Johns Hopkins Univerisity, Baltimore
Mengambil pesertaFasa 4
Umur 1 hingga 17 · Semua jantina · Dikemas kini 20 Apr 2026 · NCT06116526

Registry for Systemic Eczema Treatments

  • Johns Hopkins University, Baltimore
Mengambil pesertaKajian pemerhatian
Umur 1 hingga 26 · Semua jantina · Dikemas kini 7 Apr 2026 · NCT06136767

Real-world Experience Using Nemolizumab in the Treatment of Moderate-to-Severe Atopic Dermatitis in Adolescents & Adults

  • Galderma Investigational Site 7098, Columbia
  • Galderma Investigational Site 8012, Glenn Dale
  • Galderma Investigational Site 7068, Rockville
Mengambil pesertaKajian pemerhatian
Umur 12 ke atas · Semua jantina · Dikemas kini 13 Mac 2026 · NCT06988605

Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.